Evidence map›Paper›PMID 38419602›Full record

ArticleInternational journal of cardiology. Heart & vasculature2024

Burden of ischemic heart disease in the Middle East and North Africa (MENA) and attributable risk factors: An epidemiological analysis from 1990 to 2019.

Mohammad Ahmadi, Shana Ahadi, Mohammad Amin Khadembashiri, Mohamad Mehdi Khadembashiri, Mehrdad Mahalleh, Hani AziziKia, Hamid Reza Zare, Amir Sobh Rakhshan Khah, Hamidreza Hekmat, Rajabali Daroudi and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Mohammad AhmadiStudents' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Shana AhadiSchool of Medicine, Jondishapour University of Medical Sciences, Ahvaz, Iran.
Mohammad Amin KhadembashiriStudents' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohamad Mehdi KhadembashiriStudents' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mehrdad MahallehStudents' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hani AziziKiaStudent Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
Hamid Reza ZareStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Amir Sobh Rakhshan KhahSepehr Heart Center, Baharloo Hospital, Tehran University of Medical Science, Tehran, Iran.
Hamidreza HekmatSchool of Medicine, Ziaeian Hospital, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
Rajabali DaroudiDepartment of Health Management, Policy and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Ali Akbari SariSchool of Medicine, Ziaeian Hospital, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRAhvaz Jundishapur University of Medical Sciences · IRShahroud University of Medical Sciences · IRShiraz University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite the burden of ischemic heart disease (IHD), there remains a paucity of research on the incidence, mortality, and burden of this condition in the Middle East and North Africa (MENA) regions. This study aimed to evaluate the epidemiology and the risk factors associated with IHD in the MENA region. Methods: This study was performed based on the GBD study 2019 data. We retrieved the data related to the epidemiology and burden of IHD, including prevalence, incidence, years of life lost due to premature death (YLLs), years lived with disability (YLDs), and mortality at the global level and in MENA countries across years and sexes. Results: IHD accounted for approximately 2.55 million (95 % UI 2.29-2.83) incident cases in MENA in 2019, with an age-standardized incidence rate of 613.87 (95 % UI 555.84-675.16) per 100 000 people, which has decreased by 9 % between 1990 and 2019. IHD accounted for 11.01 % of DALYs causes in MENA in 2019, an increase of 68 % compared to 1990. The DALYs rate from IHD increased with age in both men and women and was higher in men than in women in all age groups, except 85-89 years age-group, in 2019. Conclusion: The age-standardized prevalence and incidence of IHD are decreasing in MENA. However, this reduction is lower than the global level, which can be due to a weaker performance of the countries in the region in reducing the prevalence and incidence of the disease compared to the global average.

Indexed as

BurdenEpidemiologyIschemic heart diseaseMENA

Identifiers

PMID38419602
PMCPMC10899721
OpenAlexW4389287030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.